Related Experiment Video
Updated: May 15, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Round Cell Vaginal Malignant Melanoma: A rare entity
Neena Chauhan1, Dushyant S Gaur, Ved P Pathak
1Department of Pathology, Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, Uttarakhand, India.
Sultan Qaboos University Medical Journal
|January 1, 2013
Summary
This study details a rare case of round cell pigmented malignant melanoma in the vagina, misdiagnosed initially as a urethral caruncle. Malignant vaginal melanoma has a poor prognosis, with tumor size significantly impacting survival rates.
Area of Science:
- Oncology
- Dermatology
- Gynecologic Oncology
Background:
- Malignant melanoma typically affects the skin but can rarely occur in extragenital sites.
- Vaginal melanoma is an exceptionally rare clinical diagnosis.
- Round cell pigmented malignant melanoma represents an uncommon histological variant.
Purpose of the Study:
- To report a rare case of round cell pigmented malignant melanoma initially misdiagnosed as a urethral caruncle.
- To discuss the clinical presentation, diagnosis, and poor prognosis associated with malignant vaginal melanoma.
- To highlight the prognostic significance of tumor size in malignant vaginal melanoma.
Main Methods:
- Clinical diagnosis of a suspected urethral caruncle.
- Histopathological examination and immunohistochemical staining for definitive diagnosis.
- Review of treatment outcomes and survival data for malignant vaginal melanoma.
Main Results:
- The patient was diagnosed with round cell pigmented malignant melanoma via histopathology and immunostaining.
- Despite radiotherapy, the patient died within a year.
- Malignant vaginal melanoma exhibits a poor prognosis, with a 5-year survival rate of 10-20%.
- Tumor size ≥3cm is associated with a poor prognosis.
- Age, mitotic count, stage, and location did not significantly influence survival rates in this context.
Conclusions:
- Malignant vaginal melanoma, particularly the round cell variant, is a rare and aggressive malignancy.
- Early and accurate diagnosis is crucial, although prognosis remains poor.
- Tumor size is a critical prognostic factor, with larger lesions indicating a worse outcome.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

